Effects of acupuncture on pain amd impairement in patients with osteoarthritis of the hip;Einfluss der Nadelakupunktur auf schmerzwahrnehmung und funktionseinschrankung bei patienten mit koxarthrose

Zeitschrift fur Rheumatologie

Volumn 59, Issue 3, 2000, Pages 191-199

  Fink, M G ^a   Kunsebeck H W ^a   Wippermann, B ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Acupuncture; Clinical trial; Hip; Osteoarthritis; Pain

Indexed keywords

ACUPUNCTURE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COXITIS; DAILY LIFE ACTIVITY; HUMAN; PAIN; PAIN ASSESSMENT; PATIENT SATISFACTION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

EID: 0033943362     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003930070080     Document Type: Article

References (26)

1. 1. Bellamy N (1995) Outcome measurement in osteoarthritis clinical trials. J Rheumatol 43 Suppl:49-51
2. 2. Borkovec TD, Nau SD (1972) Credibility of analogue therapy rationales. J Beh Ther Exp Psychiat 3:257-260
3. 3. Bowsher D (1990) Physiology and pathophysiology of pain. J Br Med Acup Soc 7:17-20
4. 4. Bullinger M, Kirchberger I, Steinbüchel N (1993) Der Fragebogen Alltagsleben - ein Verfahren zur Erfassung der gesundheitsbezogenen Lebensqualität. Z Med Psychol 3:121-131
5. 5. Carlsson AM (1983) Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain 16:87-101
6. 6. Cheng X ed (1990) Chinese Acupuncture and Moxibustion, 2nd ed., Foreign languages Press, Beijing
7. 7. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1993) Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328(4):246-252
8. 8. Ernst E (1997) Acupuncture as a symptomatic treatment of osteoarthritis. A systematic review. Scand J Rheumatol 26(6):444-447
9. 9. Huskisson EC (1974) Measurement of pain. Lancet 2:1127-1131
10. 10. Jarvis WT (1992) Quackery: a national scandal. Clin Chem 8:1574-1586
11. 11. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494-502
12. 12. Kubiena G (1989) Überlegungen zum Placeboproblem in der Akupunktur. Reflektionen über Sinnhaftigkeit, ethische Berechtigung, Normierung und differenzierten Einsatz von Placebos in der Akupunktur. Wien Klin Wochenschr 101:362-367
13. 13. Lautenschläger J (1997) Acupuncture in treatment of inflammatory rheumatic diseases. Z Rheumatol 56(1):8-20
14. 14. Le-Bars D, Dickenson, AH, Besson JM. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain 6:283-304
15. 15. Le-Bars D, Dickenson AH, Besson JM (1979) Diffuse noxious inhibitory controls (DNIC). II. Lack of effect on nonconvergent neurones, supraspinal involvement and theoretical implications. Pain 6:305-327
16. 16. Lequesne M, Brandt K, Bellamy N, Moskowitz R, Menkes CJ, Pelletier JP, Altman R (1994) Guidelines for testing slow acting drugs in osteoarthritis. J Rheumatol 41, Suppl:65-71
17. 17. Lequesne MG, Samson M (1991) Indices of severity in osteoarthritis for weight bearing joints. J Rheumatol 27, Suppl:16-18
18. 18. Lewith GT, Machin D (1983) On the evaluation of the clinical effects of acupuncture. Pain 16:111-127
19. 19. Melzack R, Wall PD (1965) Pain mechanisms: a new theory. Science 150:971-979
20. 20. Melzack R (1976) Akupunktur und Schmerzbeeinflussung Anaesthesist 25: 204-207
21. 21. O'Connor J, Bensky D (1992) Acupuncture. A Comprehensive Text. 9th ed., Eastland Press, Seattle
22. 22. Schermelleh-Engel K (1995) Fragebogen zur Schmerzregulation (FSR) Hogrefe, Göttingen
23. 23. Vincent C, Lewith G (1995) Placebo controls for acupuncture studies. J R Soc Med 88:199-202
24. 24. Wall PD (1993) Pain and the placebo response. Ciba Found Symp 174:187-211
25. 25. Guidelines for the Clinical Evaluation of Anti-Inflammatory and Anti-rheumatic Drugs (Adults and Children), US Department of Health and Human Services, Public Health Service, Food and Drug Administration, April 1988, 12-15
26. 26. Guidelines for the Clinical Investigation of Drugs Used in Rheumatic Diseases, European Drug Guidelines Series 5, World Health Organization, Regional Office for Europe, Copenhagen, European League Against Rheumatism, March 1985, 21-24